我想看一级黄色片_欧美性爱无遮挡电影_色丁香视频网站中文字幕_视频一区 视频二区 国产,日本三级理论日本电影,午夜不卡免费大片,国产午夜视频在线观看,18禁无遮拦无码国产在线播放,在线视频不卡国产在线视频不卡 ,,欧美一及黄片,日韩国产另类

訂閱

多平臺(tái)閱讀

微信訂閱

雜志

申請(qǐng)紙刊贈(zèng)閱

訂閱每日電郵

移動(dòng)應(yīng)用

專欄 - 從華爾街到硅谷

谷歌抗衰老公司揭秘

Dan Primack 2013年10月11日

Dan Primack專注于報(bào)道交易和交易撮合者,,從美國(guó)金融業(yè)到風(fēng)險(xiǎn)投資業(yè)均有涉及。此前,,Dan是湯森路透(Thomson Reuters)的自由編輯,,推出了peHUB.com和peHUB Wire郵件服務(wù)。作為一名新聞工作者,,Dan還曾在美國(guó)馬薩諸塞州羅克斯伯里經(jīng)營(yíng)一份社區(qū)報(bào)紙,。目前他居住在波士頓附近。
鑒于人類基因圖譜已經(jīng)得到破解,,谷歌新成立的這家公司希望從基因?qū)用嫒胧?,研究?dǎo)致人類衰老的原因,,同時(shí)研制出抗衰老的藥物。就好比如果有機(jī)會(huì)向精靈許三個(gè)愿,,你第一個(gè)愿望肯定是希望能再許100萬個(gè)愿望,。

????至于說這個(gè)新公司的管理問題,,據(jù)說馬里斯一開始就想著要來管理它,同時(shí)卻又保持自己在谷歌創(chuàng)投中的位置(有點(diǎn)像杰克?多西所做的那樣),。不過他也廣泛征求各方意見,,請(qǐng)求推薦首席執(zhí)行官的人選。馬里斯求教的人中就有阿特?列文森,,他居然真的打算加盟,,這真是讓人大跌眼鏡(如果大家沒把他看成是已經(jīng)從首席管理層崗位上徹底引退的話,他卻也是這個(gè)職位的不二人選),。

????列文森已經(jīng)開始為新公司物色人選了,。在硅谷的一些人看來,這家公司更像是一家要做長(zhǎng)期研究的機(jī)構(gòu),,而不是那種幾年里就準(zhǔn)備上臨床試驗(yàn)的生物制藥初創(chuàng)企業(yè),。隨著更多人開始準(zhǔn)備為Calico公司效力(或是打算這么做),我們也會(huì)了解到更多情況,。

????不過現(xiàn)在我們掌握的情況是,,這家公司不差錢,比多數(shù)大型藥企都更靈活,,而且在谷歌最終操盤前,它還吸引了眾多業(yè)界知名的投資機(jī)構(gòu)的關(guān)注,。再者,,它的掌門人是一位多數(shù)生命科學(xué)企業(yè)會(huì)不惜一切代價(jià)都想聘請(qǐng)的高人。所以說,,它的開局還真是不賴,。(財(cái)富中文網(wǎng))

????譯者:清遠(yuǎn)??

????As for management, Maris is said to have originally thought about helping to run the new company, while also maintaining his Google Ventures role (kind of a Jack Dorsey sort of thing). But he also reached out to various folks to get names for prospective CEOs. Among those from whom he sought advice was Art Levinson, who surprisingly threw his own hat into the ring (and would have been the obvious choice for this sort of thing, if everyone hadn't viewed him as permanently retired from the C-suite).

????Levinson already has begun interviewing people for positions at Calico, which some in the Valley are viewing as more of a long-term research institute than a biopharma startup that will be in clinical trials within a couple of years. As more people begin to work at Calico (or at least try to), we'll likely learn more about it.

????For now, however, what we know is that the effort is very well-funded with more flexibility than most big pharma, and that it was appealing to a wide swath of respected investors before Google swept in. Plus, it's led by someone who most other life sciences companies would have given their left lab to hire. Not a bad start…?

上一頁 1 2

我來點(diǎn)評(píng)

  最新文章

最新文章:

中國(guó)煤業(yè)大遷徙

500強(qiáng)情報(bào)中心

財(cái)富專欄